Literature DB >> 20804930

What you can't feel can hurt you.

Andrew J M Boulton1.   

Abstract

Throughout our medical training, we are taught how to manage patients who present with symptoms, which usually leads to a clinical examination, a diagnosis, and a management plan. However, virtually no time is spent on teaching how to manage patients who have no symptoms because they have lost the ability to feel pain; that is, they have peripheral neuropathy. The lifetime incidence of foot ulceration in people with diabetes has been estimated to be as high as 25%, and a number of contributory factors result in a foot being at risk of ulceration. Most important amongst these factors is peripheral neuropathy, or the loss of the ability to feel pain, temperature, or pressure sensation in the feet and lower legs. Up to 50% of older patients with type 2 diabetes have evidence of sensory loss that puts them at risk of foot ulceration. If we are to succeed in reducing the high incidence of foot ulcers, regular screening for peripheral neuropathy is vital in all patients with diabetes. Those found to have any risk factors for foot ulceration require special education and more frequent review, particularly with podiatrists. The key message is therefore that neuropathic symptoms correlate poorly with sensory loss, and their absence must never be equated with lack of risk of foot ulceration. If we are to succeed in reducing the high incidence of foot ulceration and, particularly, recurrent ulceration, we must realize that with loss of pain there is also diminished motivation in the healing and the prevention of injury.
Copyright © 2010 Society for Vascular Surgery and the American Podiatric Medical Association. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20804930     DOI: 10.1016/j.jvs.2010.06.005

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  15 in total

1.  [Neuropathy and diabetic foot ulcers].

Authors:  R Lobmann
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

2.  Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.

Authors:  Meryl Brod; Steven I Blum; Donald M Bushnell; Abhilasha Ramasamy
Journal:  Qual Life Res       Date:  2015-06-12       Impact factor: 4.147

Review 3.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study.

Authors:  Meryl Brod; Betsy Pohlman; Steven I Blum; Abhilasha Ramasamy; Robyn Carson
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

5.  The cost utility of a multi-disciplinary foot protection clinic (MDFPC) in an Irish hospital setting.

Authors:  G J Nason; H Strapp; C Kiernan; K Moore; J Gibney; T M Feeley; B Egan; S Tierney
Journal:  Ir J Med Sci       Date:  2012-04-21       Impact factor: 1.568

Review 6.  Neuropathy and Diabetic Foot Syndrome.

Authors:  Maren Volmer-Thole; Ralf Lobmann
Journal:  Int J Mol Sci       Date:  2016-06-10       Impact factor: 5.923

7.  Median nerve conduction impairment in patients with diabetes and its impact on patients' perception of health condition: a quantitative study.

Authors:  Jolanta Lewko; Barbara Polityńska; Jan Kochanowicz; Wiesław Zarzycki; Zenon Mariak; Maria Górska; Elżbieta Krajewska-Kułak
Journal:  Diabetol Metab Syndr       Date:  2013-03-25       Impact factor: 3.320

8.  RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.

Authors:  Judyta K Juranek; Matthew S Geddis; Fei Song; Jinghua Zhang; Jose Garcia; Rosa Rosario; Shi Fang Yan; Thomas H Brannagan; Ann Marie Schmidt
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

9.  Electrochemical skin conductance to detect sudomotor dysfunction, peripheral neuropathy and the risk of foot ulceration among Saudi patients with diabetes mellitus.

Authors:  Eman Sheshah; Amal Madanat; Fahad Al-Greesheh; Dalal Al-Qaisi; Mohammad Al-Harbi; Reem Aman; Abdul Aziz Al-Ghamdi; Khaled Al-Madani
Journal:  J Diabetes Metab Disord       Date:  2016-08-05

10. 

Authors:  Guilherme Pereira Carlesso; Mariana Helena Barboza Gonçalves; Dorival Moreschi
Journal:  J Vasc Bras       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.